Eric C. M. Van Gorp

ORCID: 0000-0001-6415-6678
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Viral Infections and Vectors
  • Mosquito-borne diseases and control
  • Sepsis Diagnosis and Treatment
  • COVID-19 Clinical Research Studies
  • HIV/AIDS Research and Interventions
  • HIV Research and Treatment
  • Viral Infections and Outbreaks Research
  • SARS-CoV-2 and COVID-19 Research
  • HIV/AIDS drug development and treatment
  • Respiratory Support and Mechanisms
  • HIV-related health complications and treatments
  • Pneumonia and Respiratory Infections
  • Respiratory viral infections research
  • Vaccine Coverage and Hesitancy
  • Venous Thromboembolism Diagnosis and Management
  • Pleural and Pulmonary Diseases
  • Hepatitis B Virus Studies
  • COVID-19 and healthcare impacts
  • Pulmonary Hypertension Research and Treatments
  • Hepatitis C virus research
  • Influenza Virus Research Studies
  • Virology and Viral Diseases
  • Blood Coagulation and Thrombosis Mechanisms
  • Long-Term Effects of COVID-19
  • Leptospirosis research and findings

Erasmus MC
2016-2025

Erasmus University Rotterdam
2016-2025

Misgav Ladach
2022

Universidad de Salamanca
2022

Rotterdam University of Applied Sciences
2015

Leiden University
2015

University of Applied Sciences Leiden
2015

Slotervaartziekenhuis
2002-2012

Academic Medical Center
2003-2012

Netherlands Organisation for Health Research and Development
2012

SARS-CoV-2 has been identified as the causative agent of a global outbreak respiratory tract disease (COVID-19). In some patients infection results in moderate to severe acute distress syndrome (ARDS), requiring invasive mechanical ventilation. High serum levels IL-6, IL-10 and an immune hyperresponsiveness referred 'cytokine storm' have associated with poor clinical outcome. Despite large numbers COVID-19 cases deaths, information on phenotype kinetics SARS-CoV-2-specific T cells is...

10.1126/sciimmunol.abd2071 article EN cc-by Science Immunology 2020-06-26

Key questions in COVID-19 are the duration and determinants of infectious virus shedding. Here, we report that shedding is detected by cultures 23 129 patients (17.8%) hospitalized with COVID-19. The median 8 days post onset symptoms (IQR 5-11) drops below 5% after 15.2 (95% confidence interval (CI) 13.4-17.2). Multivariate analyses identify viral loads above 7 log10 RNA copies/mL (odds ratio [OR] 14.7 (CI 3.57-58.1; p < 0.001) as independently associated isolation SARS-CoV-2 from...

10.1038/s41467-020-20568-4 article EN cc-by Nature Communications 2021-01-11

ABSTRACT Background Long-term shedding of viral RNA in COVID-19 prevents timely discharge from the hospital or de-escalation infection prevention and control practices. Key questions are duration determinants infectious virus shedding. We assessed these using cultures respiratory tract samples hospitalized patients as a proxy for Methods Clinical virological data were obtained 129 (89 intensive care, 40 medium care). Generalized estimating equations used to identify if load, detection...

10.1101/2020.06.08.20125310 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2020-06-09

In July 2022, the ongoing monkeypox (MPX) outbreak was declared a public health emergency of international concern. Modified vaccinia Ankara-Bavarian Nordic (MVA-BN, also known as Imvamune, JYNNEOS or Imvanex) is third-generation smallpox vaccine that authorized and in use against MPX. To date, there are no data showing MPX virus (MPXV)-neutralizing antibodies vaccinated individuals nor efficacy Here we show MPXV-neutralizing can be detected after MPXV infection historic vaccination....

10.1038/s41591-022-02090-w article EN cc-by Nature Medicine 2022-10-18

In the absence of a vaccine and therapeutic agent, personal hygiene physical distancing are essential measures to contain coronavirus disease 2019 pandemic.To determine whether social media campaign, targeted at gaps in behavior on distributed nationwide via digital news media, may be an effective method improve help inhibit person-to-person transmission severe acute respiratory syndrome 2.This survey study was designed uncover self-reported regarding Netherlands. A diagnostic by large...

10.1001/jamanetworkopen.2020.14323 article EN cc-by-nc-nd JAMA Network Open 2020-07-08

There is a lack of validated tools to assess potential disease progression and hospitalisation decisions in patients presenting the emergency department (ED) with suspected infection. This study aimed identify suitable blood biomarkers (MR-proADM, PCT, lactate CRP) or clinical scores (SIRS, SOFA, qSOFA, NEWS CRB-65) fulfil this unmet need. An observational derivation patient cohort by an independent secondary analysis across nine EDs. Logistic Cox regression, area under receiver operating...

10.1186/s13054-019-2329-5 article EN cc-by Critical Care 2019-02-08

Abstract COVID-19 is associated with lymphopenia and ‘cytokine storm’, but no information available on specific cellular immune responses to SARS-CoV-2. Here, we characterized SARS-CoV-2-specific CD4 + CD8 T-cells in patients acute respiratory distress syndrome. The spike protein (S) proved a potent T-cell antigen predominantly produced Th1 cytokines. These novel data are important vaccine design will facilitate evaluation of candidate immunogenicity.

10.1101/2020.04.11.20062349 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2020-04-18

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of disease 2019 (COVID-19). Little known about interplay between preexisting immunity to endemic seasonal coronaviruses and development a SARS-CoV-2-specific IgG response. We investigated kinetics, breadth, magnitude, level cross-reactivity antibodies against SARS-CoV-2 heterologous epidemic at clonal in patients with mild or severe COVID-19 as well control patients. assessed antibody reactivity nucleocapsid spike...

10.1172/jci150613 article EN Journal of Clinical Investigation 2021-09-09

Patients with inborn errors of immunity (IEI) are at increased risk severe coronavirus disease-2019 (COVID-19). Effective vaccination against COVID-19 is therefore great importance in this group, but little known about the immunogenicity vaccines these patients.We sought to study humoral and cellular immune responses after mRNA-1273 adult patients IEI.In a prospective, controlled, multicenter study, 505 IEI (common variable immunodeficiency [CVID], isolated or undefined antibody...

10.1016/j.jaci.2022.04.002 article EN cc-by Journal of Allergy and Clinical Immunology 2022-04-11

Lower respiratory tract (LRT) disease induced by severe acute syndrome coronavirus 2 (SARS-CoV-2) can deteriorate to distress (ARDS). Because the release of neutrophil extracellular traps (NETs) is implicated in ARDS pathogenesis, we investigated presence NETs and correlates pathogenesis blood LRT samples critically ill patients with COVID-19. Plasma NET levels peaked early after intensive care unit admission were correlated SARS-CoV-2 RNA load sputum neutrophil-recruiting chemokines...

10.1093/infdis/jiab050 article EN other-oa The Journal of Infectious Diseases 2021-01-25

Patients with a severe COVID-19 infection often require admission at an intensive care unit (ICU) when they develop acute respiratory distress syndrome (ARDS). Hyperinflammation plays important role in the development of ARDS COVID-19. Procalcitonin (PCT) is biomarker which may be predictor hyperinflammation. When patients are emergency department (ED), elevated PCT levels could associated infections. The goal this study to investigate association between and infections ED.This was...

10.1186/s12879-022-07144-5 article EN cc-by BMC Infectious Diseases 2022-02-21

Background Severe dengue virus (DENV) disease is associated with extensive immune activation, characterized by a cytokine storm. Previously, elevated lipopolysaccharide (LPS) levels in were found to correlate clinical severity. In the present cross-sectional study we identified markers of microbial translocation and which are severe manifestations DENV infection. Methods Serum samples from DENV-infected patients collected during outbreak 2010 State São Paulo, Brazil. Levels LPS, binding...

10.1371/journal.pntd.0002236 article EN cc-by PLoS neglected tropical diseases 2013-05-23

Background During a dengue outbreak on the Caribbean island Aruba, highly elevated levels of ferritin were detected in virus infected patients. Ferritin is an acute-phase reactant and hyperferritinaemia hallmark diseases caused by extensive immune activation, such as haemophagocytic lymphohistiocytosis. The aim this study was to investigate whether patients associated with clinical markers activation coagulation disturbances. Methodology/Principal Findings Levels ferritin, standard...

10.1371/journal.pntd.0003214 article EN cc-by PLoS neglected tropical diseases 2014-10-09
Anne Boerekamps Astrid M. Newsum Colette Smit Joop E. Arends Clemens Richter and 95 more Peter Reiss Bart Rijnders Kees Brinkman Marc van der Valk Suzanne E. Geerlings Mieke H. Godfried Abraham Goorhuis Joppe W. Hovius Jan T. M. van der Meer TW Kuijpers F.J.B. Nellen D T van der Poll Jan M. Prins H J M van Vugt W. Joost Wiersinga F W M N Wit Marlies van Duinen J. van Eden A M H van Hes M Mutschelknauss H. Nobel F J J Pijnappel Annouschka M. Weijsenfeld Suzanne Jurriaans Nicole Back Hans L. Zaaijer B. Berkhout Marion Cornelissen C. Schinkel Katja C. Wolthers Maarten van den Berge Arjan Stegeman S. Baas L. Hage de Looff Bas Wintermans Jacobien Veenemans M.J.H. Pronk Heidi S. M. Ammerlaan E. S. de Munnik A R Jansz Jeroen H. T. Tjhie M.C.A. Wegdam Birgit Deiman Volkher Scharnhorst Arne van Eeden Dandan Ma W. Brokking Marco R. de Groot L. Elsenburg M. Damen I S Kwa M.E.E. van Kasteren A.E. Brouwer R. van Erve B.A.F.M. de Kruijf-van de Wiel S Keelan-Pfaf B van der Ven B.A.F.M. de Kruijf-van de Wiel B van der Ven A. G. M. Buiting Peter Kabel Donald J. Versteeg Marc van der Valk Hannelore I. Bax Eric C. M. Van Gorp Jan Nouwen Carolina A. M. Schurink Annelies Verbon T.E.M.S. de Vries-Sluijs N. C. de Jong-Peltenburg N. Bassant J. E. A. van Beek M. Vriesde L.M. van Zonneveld H J van den Berg-Cameron Joris R. de Groot M de Zeeuw-de Man Charles A. Boucher Marion Koopmans Jeroen J. A. van Kampen Suzan D. Pas Judith Branger A Rijkeboer-Mes C.J.H.M. Duijf-van de Ven Emile F. Schippers Cees van Nieuwkoop J M van IJperen J. Geilings G. van der Hut Nathalie D. van Burgel Den Haag Eliane M.S. Leyten L. B. S. Gelinck A Y van Hartingsveld C Meerkerk

The Netherlands has provided unrestricted access to direct-acting antivirals (DAAs) since November 2015. We analyzed the nationwide hepatitis C virus (HCV) treatment uptake among patients coinfected with human immunodeficiency (HIV) and HCV.Data were obtained from ATHENA HIV observational cohort in which >98% of HIV-infected ever registered 1998 are included. Patients included if they had 1 positive HCV RNA result, did not have spontaneous clearance, known still be care. Treatment outcome...

10.1093/cid/cix1004 article EN Clinical Infectious Diseases 2017-11-20
Colette Smit Anders Boyd Bart Rijnders Thijs van de Laar Eliane M.S. Leyten and 95 more Wouter F.W. Bierman Kees Brinkman Mark A. A. Claassen Jan den Hollander Anne Boerekamps Astrid M. Newsum Janke Schinkel Maria Prins Joop E. Arends Eline Op de Coul Marc van der Valk Peter Reiss Marc van der Valk Suzanne E. Geerlings Abraham Goorhuis Joppe W. Hovius B. Lempkes F.J.B. Nellen T. van der Poll Jan M. Prins Michèle van Vugt W. Joost Wiersinga F.W.M.N. Wit Marlies van Duinen J. van Eden A. Hazenberg A M H van Hes F J J Pijnappel S Smalhout Annouschka M. Weijsenfeld Suzanne Jurriaans Nicole Back Hans L. Zaaijer B. Berkhout Marion Cornelissen C. Schinkel Katja C. Wolthers Edgar J.G. Peters Michiel A. van Agtmael Reshma Autar Marije K. Bomers Kim Sigaloff M. Heitmuller Liedewij Laan C. Wim Ang Robin van Houdt Marcel Jonges Maarten van den Berge Arjan Stegeman S. Baas L. Hage de Looff A. G. M. Buiting Anne Q. Reuwer Jacobien Veenemans Bas Wintermans M.J.H. Pronk Heidi S. M. Ammerlaan D. N. J. van den Bersselaar E. S. de Munnik Birgit Deiman A R Jansz Volkher Scharnhorst Jeroen H. T. Tjhie M.C.A. Wegdam Arne van Eeden Jeannine F. Nellen W. Brokking L. Elsenburg H. Nobel C. Schinkel M.E.E. van Kasteren Marvin A. H. Berrevoets Annemarie E. Brouwer Andrew L. Adams R. van Erve B.A.F.M. de Kruijf-van de Wiel S. Keelan-Phaf B. van de Ven A. G. M. Buiting J.L. Murck T.E.M.S. de Vries-Sluijs Hannelore I. Bax Eric C. M. Van Gorp N. C. de Jong-Peltenburg Martim Melo Els van Nood Jan Nouwen Bart Rijnders Casper Rokx Carolina A. M. Schurink Lennert Slobbe Annelies Verbon N. Bassant J. E. A. van Beek M. Vriesde

10.1016/s2352-3018(20)30301-5 article EN The Lancet HIV 2020-12-22

As several COVID-19 vaccines are rolled-out globally, it has become important to develop an effective strategy for vaccine acceptance, especially in high-risk groups, such as elderly. Vaccine misconception was declared by WHO one of the top 10 health issues 2019. Here we test effectiveness applying debunking combat misinformation, and reduce hesitancy.Participants were recruited via a daily news show on Dutch Television, targeted elderly viewers. The study conducted 980 citizens during...

10.1016/j.eclinm.2021.100881 article EN cc-by EClinicalMedicine 2021-05-01
Coming Soon ...